Matthew Gall insider trades

Open-market stock purchases and sales by Matthew Gall, Chief Financial Officer at Tango Therapeutics, Inc, from SEC Form 4 filings since Mar 1, 2021.

Recent trades

DateStockTradeValue
May 1, 2026TNGX Tango Therapeutics, IncBought (not open market)—
May 1, 2026TNGX Tango Therapeutics, IncBought (not open market)—
Mar 19, 2026KLRS Kalaris Therapeutics, IncBought (not open market)—
Nov 3, 2025KLRS Kalaris Therapeutics, IncBought (not open market)—

Companies traded

  • TNGX Tango Therapeutics, Inc: other filings, last May 1, 2026
  • KLRS Kalaris Therapeutics, Inc: other filings, last Mar 19, 2026
  • ITOS iTeos Therapeutics, Inc: 3 buys, 1 sale, last Aug 29, 2025

Get free alerts when Matthew Gall files a new trade →